Literature DB >> 30049375

Osimertinib Depletes EGFR T790M in the Spinal Fluid of Patients with Carcinomatous Meningitis of Lung Adenocarcinoma Harboring De Novo EGFR T790M.

Satoru Senoo1, Kadoaki Ohashi2, Kazuya Nishii1, Naofumi Hara3, Hirohisa Kano3, Kiichiro Ninomiya4, Yoshinobu Maeda4, Katsuyuki Kiura3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30049375     DOI： 10.1016/j.jtho.2018.03.016

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction.

Authors:  Kazuya Nishii; Kadoaki Ohashi; Tomoki Tamura; Kiichiro Ninomiya; Takehiro Matsubara; Satoru Senoo; Hirohisa Kano; Hiromi Watanabe; Naohiro Oda; Go Makimoto; Hisao Higo; Yuka Kato; Takashi Ninomiya; Toshio Kubo; Hiromasa Yamamoto; Shuta Tomida; Katsuyuki Hotta; Masahiro Tabata; Shinichi Toyooka; Yoshinobu Maeda; Katsuyuki Kiura
Journal:  Oncol Lett       Date:  2020-10-29       Impact factor: 2.967

2.  Osimertinib Administration as the Primary Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy for Brain Metastasis of De Novo T790M-positive Lung Cancer.

Authors:  Susumu Noguchi; Hiroaki Kawachi; Akari Fukao; Satoshi Terashita; Tomoko Tajiri; Tatsuyoshi Ikeue; Sadao Horikawa; Takakazu Sugita
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

3.  Long-term response to osimertinib in elderly patients with lung adenocarcinoma harbouring de novo EGFR T790M: a case report and literature review.

Authors:  Toshiyuki Sumi; Koki Kamada; Naoki Shijubou; Yuichi Yamada; Hisashi Nakata; Yuji Mori; Hirofumi Chiba
Journal:  Respirol Case Rep       Date:  2021-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.